Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis

[Display omitted] Melioidosis, a potentially lethal disease of humans and animals, is caused by the soil-dwelling bacterium Burkholderia pseudomallei. Due to B. pseudomallei’s classification as a Tier 1 Select Agent, there is substantial interest in the development of an effective vaccine. Yet, desp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2015-11, Vol.495 (2), p.849-861
Hauptverfasser: Schully, K.L., Bell, M.G., Prouty, A.M., Gallovic, M.D., Gautam, S., Peine, K.J., Sharma, S., Bachelder, E.M., Pesce, J.T., Elberson, M.A., Ainslie, K.M., Keane-Myers, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 861
container_issue 2
container_start_page 849
container_title International journal of pharmaceutics
container_volume 495
creator Schully, K.L.
Bell, M.G.
Prouty, A.M.
Gallovic, M.D.
Gautam, S.
Peine, K.J.
Sharma, S.
Bachelder, E.M.
Pesce, J.T.
Elberson, M.A.
Ainslie, K.M.
Keane-Myers, A.
description [Display omitted] Melioidosis, a potentially lethal disease of humans and animals, is caused by the soil-dwelling bacterium Burkholderia pseudomallei. Due to B. pseudomallei’s classification as a Tier 1 Select Agent, there is substantial interest in the development of an effective vaccine. Yet, despite decades of research, no effective target, adjuvant or delivery vehicle capable of inducing protective immunity against B. pseudomallei infection has been identified. We propose a microparticulate delivery vehicle comprised of the novel polymer acetalated dextran (Ac-DEX). Ac-DEX is an acid-sensitive biodegradable carrier that can be fabricated into microparticles (MPs) that are relatively stable at pH 7.4, but rapidly degrade after phagocytosis by antigen presenting cells where the pH can drop to 5.0. As compared to other biomaterials, this acid sensitivity has been shown to enhance cross presentation of subunit antigens. To evaluate this platform as a delivery system for a melioidosis vaccine, BALB/c mice were vaccinated with Ac-DEX MPs separately encapsulating B. pseudomallei whole cell lysate and the toll-like receptor (TLR) 7/8 agonist resiquimod. This vaccine elicited a robust antibody response that included both Th1 and Th2 immunity. Following lethal intraperitoneal challenge with B. pseudomallei 1026b, vaccinated mice demonstrated a significant delay to time of death compared to untreated mice. The formulation, however, demonstrated incomplete protection indicating that lysate protein offers limited value as an antigen. Nevertheless, our Ac-DEX MPs may offer an effective delivery vehicle for a subunit B. psuedomallei vaccine.
doi_str_mv 10.1016/j.ijpharm.2015.09.059
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1730025536</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037851731530257X</els_id><sourcerecordid>1730025536</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-206f2c40359333f6a95e5d6c2447304937a191804d1bcf6e901f04e8e44330e73</originalsourceid><addsrcrecordid>eNqFkc2O1DAQhC0EYoeFRwD5yCVDO3ac5IRgtfxIK3GBs-XYHbYHJw52MtK-xj4xHs3AlVPL0ldd7SrGXgvYCxD63WFPh-Xepmlfg2j20O-h6Z-wnehaWUnV6qdsB7Ltqka08oq9yPkAALoW8jm7qrWqOy3Fjj3eHm3Y7Epx5nHklg8UPf5M1tshIJ_IpbjYtJLbgl2RLzE8TJi4zYV1NiUqjzEm_nFLv-5j8JjI8iXj5uNkQ0DieRu2mVZ-tM7RjJnTXLRT3HLZX8zCyXjCQJF8zJRfsmejDRlfXeY1-_Hp9vvNl-ru2-evNx_uKqdEvVY16LF2CmTTSylHbfsGG69drVQrQfWytaIXHSgvBjdq7EGMoLBDpaQEbOU1e3veu6T4e8O8momywxDsjOU4U3IDqJtG6oI2Z7SkkXPC0SyJJpsejABzqsMczKUOc6rDQG9KHUX35mKxDRP6f6q_-Rfg_RnA8tFjydJkRzg79JTQrcZH-o_FH05aoKU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1730025536</pqid></control><display><type>article</type><title>Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Schully, K.L. ; Bell, M.G. ; Prouty, A.M. ; Gallovic, M.D. ; Gautam, S. ; Peine, K.J. ; Sharma, S. ; Bachelder, E.M. ; Pesce, J.T. ; Elberson, M.A. ; Ainslie, K.M. ; Keane-Myers, A.</creator><creatorcontrib>Schully, K.L. ; Bell, M.G. ; Prouty, A.M. ; Gallovic, M.D. ; Gautam, S. ; Peine, K.J. ; Sharma, S. ; Bachelder, E.M. ; Pesce, J.T. ; Elberson, M.A. ; Ainslie, K.M. ; Keane-Myers, A.</creatorcontrib><description>[Display omitted] Melioidosis, a potentially lethal disease of humans and animals, is caused by the soil-dwelling bacterium Burkholderia pseudomallei. Due to B. pseudomallei’s classification as a Tier 1 Select Agent, there is substantial interest in the development of an effective vaccine. Yet, despite decades of research, no effective target, adjuvant or delivery vehicle capable of inducing protective immunity against B. pseudomallei infection has been identified. We propose a microparticulate delivery vehicle comprised of the novel polymer acetalated dextran (Ac-DEX). Ac-DEX is an acid-sensitive biodegradable carrier that can be fabricated into microparticles (MPs) that are relatively stable at pH 7.4, but rapidly degrade after phagocytosis by antigen presenting cells where the pH can drop to 5.0. As compared to other biomaterials, this acid sensitivity has been shown to enhance cross presentation of subunit antigens. To evaluate this platform as a delivery system for a melioidosis vaccine, BALB/c mice were vaccinated with Ac-DEX MPs separately encapsulating B. pseudomallei whole cell lysate and the toll-like receptor (TLR) 7/8 agonist resiquimod. This vaccine elicited a robust antibody response that included both Th1 and Th2 immunity. Following lethal intraperitoneal challenge with B. pseudomallei 1026b, vaccinated mice demonstrated a significant delay to time of death compared to untreated mice. The formulation, however, demonstrated incomplete protection indicating that lysate protein offers limited value as an antigen. Nevertheless, our Ac-DEX MPs may offer an effective delivery vehicle for a subunit B. psuedomallei vaccine.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2015.09.059</identifier><identifier>PMID: 26428631</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject><![CDATA[Acid-labile ; Animals ; Bacterial vaccine ; Bacterial Vaccines - administration & dosage ; Bacterial Vaccines - immunology ; Biodegradable Plastics - chemistry ; Biodegradable polymer ; Bioterrorism agent ; Burkholderia pseudomallei - immunology ; Dextrans - administration & dosage ; Dextrans - chemistry ; Disease Models, Animal ; Drug Carriers - administration & dosage ; Drug Carriers - chemistry ; Imidazoles - administration & dosage ; Imidazoles - chemistry ; Melioidosis - immunology ; Melioidosis - prevention & control ; Mice ; Polymers - administration & dosage ; Polymers - chemistry ; Subunit vaccine ; Vaccination - methods ; Vaccines, Subunit - administration & dosage ; Vaccines, Subunit - immunology]]></subject><ispartof>International journal of pharmaceutics, 2015-11, Vol.495 (2), p.849-861</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-206f2c40359333f6a95e5d6c2447304937a191804d1bcf6e901f04e8e44330e73</citedby><cites>FETCH-LOGICAL-c412t-206f2c40359333f6a95e5d6c2447304937a191804d1bcf6e901f04e8e44330e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S037851731530257X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26428631$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schully, K.L.</creatorcontrib><creatorcontrib>Bell, M.G.</creatorcontrib><creatorcontrib>Prouty, A.M.</creatorcontrib><creatorcontrib>Gallovic, M.D.</creatorcontrib><creatorcontrib>Gautam, S.</creatorcontrib><creatorcontrib>Peine, K.J.</creatorcontrib><creatorcontrib>Sharma, S.</creatorcontrib><creatorcontrib>Bachelder, E.M.</creatorcontrib><creatorcontrib>Pesce, J.T.</creatorcontrib><creatorcontrib>Elberson, M.A.</creatorcontrib><creatorcontrib>Ainslie, K.M.</creatorcontrib><creatorcontrib>Keane-Myers, A.</creatorcontrib><title>Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] Melioidosis, a potentially lethal disease of humans and animals, is caused by the soil-dwelling bacterium Burkholderia pseudomallei. Due to B. pseudomallei’s classification as a Tier 1 Select Agent, there is substantial interest in the development of an effective vaccine. Yet, despite decades of research, no effective target, adjuvant or delivery vehicle capable of inducing protective immunity against B. pseudomallei infection has been identified. We propose a microparticulate delivery vehicle comprised of the novel polymer acetalated dextran (Ac-DEX). Ac-DEX is an acid-sensitive biodegradable carrier that can be fabricated into microparticles (MPs) that are relatively stable at pH 7.4, but rapidly degrade after phagocytosis by antigen presenting cells where the pH can drop to 5.0. As compared to other biomaterials, this acid sensitivity has been shown to enhance cross presentation of subunit antigens. To evaluate this platform as a delivery system for a melioidosis vaccine, BALB/c mice were vaccinated with Ac-DEX MPs separately encapsulating B. pseudomallei whole cell lysate and the toll-like receptor (TLR) 7/8 agonist resiquimod. This vaccine elicited a robust antibody response that included both Th1 and Th2 immunity. Following lethal intraperitoneal challenge with B. pseudomallei 1026b, vaccinated mice demonstrated a significant delay to time of death compared to untreated mice. The formulation, however, demonstrated incomplete protection indicating that lysate protein offers limited value as an antigen. Nevertheless, our Ac-DEX MPs may offer an effective delivery vehicle for a subunit B. psuedomallei vaccine.</description><subject>Acid-labile</subject><subject>Animals</subject><subject>Bacterial vaccine</subject><subject>Bacterial Vaccines - administration &amp; dosage</subject><subject>Bacterial Vaccines - immunology</subject><subject>Biodegradable Plastics - chemistry</subject><subject>Biodegradable polymer</subject><subject>Bioterrorism agent</subject><subject>Burkholderia pseudomallei - immunology</subject><subject>Dextrans - administration &amp; dosage</subject><subject>Dextrans - chemistry</subject><subject>Disease Models, Animal</subject><subject>Drug Carriers - administration &amp; dosage</subject><subject>Drug Carriers - chemistry</subject><subject>Imidazoles - administration &amp; dosage</subject><subject>Imidazoles - chemistry</subject><subject>Melioidosis - immunology</subject><subject>Melioidosis - prevention &amp; control</subject><subject>Mice</subject><subject>Polymers - administration &amp; dosage</subject><subject>Polymers - chemistry</subject><subject>Subunit vaccine</subject><subject>Vaccination - methods</subject><subject>Vaccines, Subunit - administration &amp; dosage</subject><subject>Vaccines, Subunit - immunology</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2O1DAQhC0EYoeFRwD5yCVDO3ac5IRgtfxIK3GBs-XYHbYHJw52MtK-xj4xHs3AlVPL0ldd7SrGXgvYCxD63WFPh-Xepmlfg2j20O-h6Z-wnehaWUnV6qdsB7Ltqka08oq9yPkAALoW8jm7qrWqOy3Fjj3eHm3Y7Epx5nHklg8UPf5M1tshIJ_IpbjYtJLbgl2RLzE8TJi4zYV1NiUqjzEm_nFLv-5j8JjI8iXj5uNkQ0DieRu2mVZ-tM7RjJnTXLRT3HLZX8zCyXjCQJF8zJRfsmejDRlfXeY1-_Hp9vvNl-ru2-evNx_uKqdEvVY16LF2CmTTSylHbfsGG69drVQrQfWytaIXHSgvBjdq7EGMoLBDpaQEbOU1e3veu6T4e8O8momywxDsjOU4U3IDqJtG6oI2Z7SkkXPC0SyJJpsejABzqsMczKUOc6rDQG9KHUX35mKxDRP6f6q_-Rfg_RnA8tFjydJkRzg79JTQrcZH-o_FH05aoKU</recordid><startdate>20151130</startdate><enddate>20151130</enddate><creator>Schully, K.L.</creator><creator>Bell, M.G.</creator><creator>Prouty, A.M.</creator><creator>Gallovic, M.D.</creator><creator>Gautam, S.</creator><creator>Peine, K.J.</creator><creator>Sharma, S.</creator><creator>Bachelder, E.M.</creator><creator>Pesce, J.T.</creator><creator>Elberson, M.A.</creator><creator>Ainslie, K.M.</creator><creator>Keane-Myers, A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151130</creationdate><title>Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis</title><author>Schully, K.L. ; Bell, M.G. ; Prouty, A.M. ; Gallovic, M.D. ; Gautam, S. ; Peine, K.J. ; Sharma, S. ; Bachelder, E.M. ; Pesce, J.T. ; Elberson, M.A. ; Ainslie, K.M. ; Keane-Myers, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-206f2c40359333f6a95e5d6c2447304937a191804d1bcf6e901f04e8e44330e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acid-labile</topic><topic>Animals</topic><topic>Bacterial vaccine</topic><topic>Bacterial Vaccines - administration &amp; dosage</topic><topic>Bacterial Vaccines - immunology</topic><topic>Biodegradable Plastics - chemistry</topic><topic>Biodegradable polymer</topic><topic>Bioterrorism agent</topic><topic>Burkholderia pseudomallei - immunology</topic><topic>Dextrans - administration &amp; dosage</topic><topic>Dextrans - chemistry</topic><topic>Disease Models, Animal</topic><topic>Drug Carriers - administration &amp; dosage</topic><topic>Drug Carriers - chemistry</topic><topic>Imidazoles - administration &amp; dosage</topic><topic>Imidazoles - chemistry</topic><topic>Melioidosis - immunology</topic><topic>Melioidosis - prevention &amp; control</topic><topic>Mice</topic><topic>Polymers - administration &amp; dosage</topic><topic>Polymers - chemistry</topic><topic>Subunit vaccine</topic><topic>Vaccination - methods</topic><topic>Vaccines, Subunit - administration &amp; dosage</topic><topic>Vaccines, Subunit - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schully, K.L.</creatorcontrib><creatorcontrib>Bell, M.G.</creatorcontrib><creatorcontrib>Prouty, A.M.</creatorcontrib><creatorcontrib>Gallovic, M.D.</creatorcontrib><creatorcontrib>Gautam, S.</creatorcontrib><creatorcontrib>Peine, K.J.</creatorcontrib><creatorcontrib>Sharma, S.</creatorcontrib><creatorcontrib>Bachelder, E.M.</creatorcontrib><creatorcontrib>Pesce, J.T.</creatorcontrib><creatorcontrib>Elberson, M.A.</creatorcontrib><creatorcontrib>Ainslie, K.M.</creatorcontrib><creatorcontrib>Keane-Myers, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schully, K.L.</au><au>Bell, M.G.</au><au>Prouty, A.M.</au><au>Gallovic, M.D.</au><au>Gautam, S.</au><au>Peine, K.J.</au><au>Sharma, S.</au><au>Bachelder, E.M.</au><au>Pesce, J.T.</au><au>Elberson, M.A.</au><au>Ainslie, K.M.</au><au>Keane-Myers, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2015-11-30</date><risdate>2015</risdate><volume>495</volume><issue>2</issue><spage>849</spage><epage>861</epage><pages>849-861</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] Melioidosis, a potentially lethal disease of humans and animals, is caused by the soil-dwelling bacterium Burkholderia pseudomallei. Due to B. pseudomallei’s classification as a Tier 1 Select Agent, there is substantial interest in the development of an effective vaccine. Yet, despite decades of research, no effective target, adjuvant or delivery vehicle capable of inducing protective immunity against B. pseudomallei infection has been identified. We propose a microparticulate delivery vehicle comprised of the novel polymer acetalated dextran (Ac-DEX). Ac-DEX is an acid-sensitive biodegradable carrier that can be fabricated into microparticles (MPs) that are relatively stable at pH 7.4, but rapidly degrade after phagocytosis by antigen presenting cells where the pH can drop to 5.0. As compared to other biomaterials, this acid sensitivity has been shown to enhance cross presentation of subunit antigens. To evaluate this platform as a delivery system for a melioidosis vaccine, BALB/c mice were vaccinated with Ac-DEX MPs separately encapsulating B. pseudomallei whole cell lysate and the toll-like receptor (TLR) 7/8 agonist resiquimod. This vaccine elicited a robust antibody response that included both Th1 and Th2 immunity. Following lethal intraperitoneal challenge with B. pseudomallei 1026b, vaccinated mice demonstrated a significant delay to time of death compared to untreated mice. The formulation, however, demonstrated incomplete protection indicating that lysate protein offers limited value as an antigen. Nevertheless, our Ac-DEX MPs may offer an effective delivery vehicle for a subunit B. psuedomallei vaccine.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26428631</pmid><doi>10.1016/j.ijpharm.2015.09.059</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2015-11, Vol.495 (2), p.849-861
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_1730025536
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acid-labile
Animals
Bacterial vaccine
Bacterial Vaccines - administration & dosage
Bacterial Vaccines - immunology
Biodegradable Plastics - chemistry
Biodegradable polymer
Bioterrorism agent
Burkholderia pseudomallei - immunology
Dextrans - administration & dosage
Dextrans - chemistry
Disease Models, Animal
Drug Carriers - administration & dosage
Drug Carriers - chemistry
Imidazoles - administration & dosage
Imidazoles - chemistry
Melioidosis - immunology
Melioidosis - prevention & control
Mice
Polymers - administration & dosage
Polymers - chemistry
Subunit vaccine
Vaccination - methods
Vaccines, Subunit - administration & dosage
Vaccines, Subunit - immunology
title Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T10%3A51%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20a%20biodegradable%20microparticulate%20polymer%20as%20a%20carrier%20for%20Burkholderia%20pseudomallei%20subunit%20vaccines%20in%20a%20mouse%20model%20of%20melioidosis&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Schully,%20K.L.&rft.date=2015-11-30&rft.volume=495&rft.issue=2&rft.spage=849&rft.epage=861&rft.pages=849-861&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2015.09.059&rft_dat=%3Cproquest_cross%3E1730025536%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1730025536&rft_id=info:pmid/26428631&rft_els_id=S037851731530257X&rfr_iscdi=true